![Cureus | Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity Cureus | Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity](https://assets.cureus.com/uploads/figure/file/150263/152cad10fe1111eaaa5f4dd30f1e81be-Screen-Shot-2020-09-21-at-4.37.22-PM.png)
Cureus | Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity
![Medication Adherence: Improve Patient Outcomes and Reduce Costs | Health Care Quality | AMA STEPS Forward | AMA Ed Hub Medication Adherence: Improve Patient Outcomes and Reduce Costs | Health Care Quality | AMA STEPS Forward | AMA Ed Hub](https://cdn.edhub.ama-assn.org/ama/content_public/journal/steps-forward/937327/stepsforward-2017-0052-f002.jpeg?Expires=2147483647&Signature=5PuCrkZzTK035lQpgEp4-m8JuNL~QkTdkqH8B2bJjOpclAVvQtVXaQ4ikO3p6oYsPamPVFUbn-QJVFpgmvzfkpKMuQQl-fJsnDGkRf99RxDKkiV2Rayu~3kOzUQDHC0rvehGhRnaVPOmfGrj2EOLCilLEbJLdfMxLmqfsVCEdsA0nf4FeOImMFX~yfsQ4oHe0TWrAjvVpLZzaA092q72pfzSTCgfsydXOUKup6XLevaP~nfEvMoFR4aou~sjQfuPLu4Xdcvur8MCVY0bZe6pjOsm4VJxmgQBM4nJcIwEhC27iTGQytHG2MnF8Bb72Tcs-hlA81AobshxmOYU-X2iNg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Medication Adherence: Improve Patient Outcomes and Reduce Costs | Health Care Quality | AMA STEPS Forward | AMA Ed Hub
![It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All‐Cause Mortality | Journal of the American Heart Association It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All‐Cause Mortality | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/5f948833-f1e1-4ed7-97a3-3815a9c85285/jah33983-fig-0004.png)
It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All‐Cause Mortality | Journal of the American Heart Association
Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medic
![Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Lipids in Health Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Lipids in Health](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-018-0918-y/MediaObjects/12944_2018_918_Fig2_HTML.png)
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Lipids in Health
![Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia](https://onlinelibrary.wiley.com/cms/asset/15646b91-9c72-422c-a0eb-efdde87eed6e/jcsm12960-gra-0005-m.jpg)
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) - Penson - 2022 - Journal of Cachexia, Sarcopenia
![Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Lipids in Health Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Lipids in Health](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-018-0918-y/MediaObjects/12944_2018_918_Fig4_HTML.png)
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis | Lipids in Health
![PDF) Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: A retrospective cost-consequences analysis PDF) Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: A retrospective cost-consequences analysis](https://i1.rgstatic.net/publication/329456667_Treatment_persistence_and_adherence_and_their_consequences_on_patient_outcomes_of_generic_versus_brand-name_statins_routinely_used_to_treat_high_cholesterol_levels_in_Spain_A_retrospective_cost-conseq/links/5c09ce2ca6fdcc494fdf6e89/largepreview.png)
PDF) Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: A retrospective cost-consequences analysis
![2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Journal of the ... 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Journal of the ...](https://www.jacc.org/cms/asset/58a2f4a8-8fdd-4284-ba71-68bac9d7c6d3/gr1.jpg?download)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Journal of the ...
![Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome | Journal of the American Heart Association Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/772cc978-e5a1-4195-ad4d-dd73e10b1683/jah31484-fig-0001.gif)